Skip to main content
construction release_alert
Profile editing is temporarily unavailable from June 11-24, 2026 while manual profile data entry transitions to Elements. Learn More.
cancel

Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial.

Publication ,  Journal Article
Weiner, I; Kahan-Hanum, M; Buchstab, N; Zelcbuch, L; Navok, S; Sherman, I; Nicenboim, J; Axelrod, T; Berko-Ashur, D; Olshina, M; Mordoch, R ...
Published in: Nature communications
February 2026

Duke Scholars

Published In

Nature communications

DOI

EISSN

2041-1723

ISSN

2041-1723

Publication Date

February 2026

Volume

17

Issue

1

Start / End Page

2057
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Weiner, I., Kahan-Hanum, M., Buchstab, N., Zelcbuch, L., Navok, S., Sherman, I., … Bassan, M. (2026). Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial. Nature Communications, 17(1), 2057. https://doi.org/10.1038/s41467-026-70146-3
Weiner, Iddo, Maya Kahan-Hanum, Nufar Buchstab, Lior Zelcbuch, Sharon Navok, Irit Sherman, Julian Nicenboim, et al. “Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial.Nature Communications 17, no. 1 (February 2026): 2057. https://doi.org/10.1038/s41467-026-70146-3.
Weiner I, Kahan-Hanum M, Buchstab N, Zelcbuch L, Navok S, Sherman I, et al. Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial. Nature communications. 2026 Feb;17(1):2057.
Weiner, Iddo, et al. “Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial.Nature Communications, vol. 17, no. 1, Feb. 2026, p. 2057. Epmc, doi:10.1038/s41467-026-70146-3.
Weiner I, Kahan-Hanum M, Buchstab N, Zelcbuch L, Navok S, Sherman I, Nicenboim J, Axelrod T, Berko-Ashur D, Olshina M, Mordoch R, Jablonska J, Gera-Inbar T, Vainberg-Slutskin I, Blumenfeld B, Sberro-Livnat H, Moses A, Nevenzel H, Levy-Saar I, Gold J, Goldberg M, Tchernorudsky N, Ben-Yishay N, Cohen T, Kario E, Levovich I, Safonov R, Tzur Y, Zarchin Y, Lev V, Elharar Y, Safyon-Gartman E, Gahali-Sass I, Puttagunta S, Ussery X, Vilchez R, Rappo U, Zak N, Golembo M, Cohen A, Koff J, Kerem E, Sorek R, Bassan M. Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial. Nature communications. 2026 Feb;17(1):2057.

Published In

Nature communications

DOI

EISSN

2041-1723

ISSN

2041-1723

Publication Date

February 2026

Volume

17

Issue

1

Start / End Page

2057